Anixa Biosciences (ANIX) SEC Filings: History & Chart

Anixa Biosciences, Inc.(ANIX)

Biotechnology · San Jose, CA

$2.95Daily change unavailable

Delayed quote: Oct 6, 2026, 11:00 AM EDT

About Anixa Biosciences, Inc.

Anixa Biosciences, Inc. (ANIX) is a biotechnology company dedicated to pioneering therapies and vaccines. Its core mission revolves around addressing critical, unmet medical needs, particularly within the fields of oncology (cancer) and infectious diseases. Among its therapeutic pipeline, Anixa is developing a novel chimeric endocrine receptor T-cell (CER-T) technology, an innovative adaptation of CAR-T, specifically for ovarian cancer treatment. The company is also engaged in the discovery and development of antiviral drug candidates to combat COVID-19, focusing on the inhibition of specific viral protein functions. On the vaccine front, Anixa's initiatives include a vaccine designed to target triple-negative breast cancer and a distinct preventative vaccine aimed at ovarian cancer. Beyond specific therapies and vaccines, Anixa also has immuno-therapy drugs for various cancers in its development portfolio. A key collaboration exists with MolGenie GmbH for the discovery and development of its COVID-19 antiviral candidates. Tracing its origins back to an incorporation in 1982, the company initially operated as ITUS Corporation before adopting the name Anixa Biosciences, Inc. in October 2018. It is headquartered in San Jose, California.

San Jose, CA

4 employees

www.anixa.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Amit Kumar

View full financials

Form	Filing Date	Accepted	Document
4	Sep 30, 2026	Sep 30, 2026	View filing
4	Sep 28, 2026	Sep 28, 2026	View filing
4	Sep 28, 2026	Sep 28, 2026	View filing
4	Sep 25, 2026	Sep 25, 2026	View filing
4	Sep 14, 2026	Sep 14, 2026	View filing
4	Sep 14, 2026	Sep 14, 2026	View filing
4	Sep 11, 2026	Sep 11, 2026	View filing
10-Q	Sep 9, 2026	Sep 9, 2026	View filing
4	Aug 3, 2026	Aug 3, 2026	View filing
4	Jul 29, 2026	Jul 29, 2026	View filing
4	Jul 28, 2026	Jul 28, 2026	View filing
4	Jul 27, 2026	Jul 27, 2026	View filing
4	Jul 27, 2026	Jul 27, 2026	View filing
4	Jul 21, 2026	Jul 21, 2026	View filing
4	Jul 20, 2026	Jul 20, 2026	View filing
4	Jul 16, 2026	Jul 16, 2026	View filing
4	Jul 13, 2026	Jul 13, 2026	View filing
4	Jun 17, 2026	Jun 17, 2026	View filing
4	Jun 16, 2026	Jun 16, 2026	View filing
10-Q	Jun 10, 2026	Jun 10, 2026	View filing
8-K	Mar 11, 2026	Mar 11, 2026	View filing
10-Q	Mar 9, 2026	Mar 9, 2026	View filing
8-K	Feb 9, 2026	Feb 9, 2026	View filing
4	Jan 29, 2026	Jan 29, 2026	View filing
DEF 14A	Jan 28, 2026	Jan 28, 2026	View filing
S-8	Jan 12, 2026	Jan 12, 2026	View filing
10-K	Jan 12, 2026	Jan 12, 2026	View filing
SC 13D/A	Jan 6, 2026	Jan 6, 2026	View filing
4	Jan 6, 2026	Jan 6, 2026	View filing
4	Jan 6, 2026	Jan 6, 2026	View filing

SEC Filings

Recent Filings